ID   MBT-2
AC   CVCL_4660
SY   MBT2; Mouse Bladder Tumor line-2
DR   BTO; BTO_0003555
DR   CLO; CLO_0050945
DR   JCRB; IFO50041
DR   RCB; RCB0544
DR   Wikidata; Q54904157
RX   DOI=10.4051/ibc.2010.2.4.0014;
RX   PubMed=406041;
RX   PubMed=16140114;
RX   PubMed=29732388;
CC   Transformant: ChEBI; CHEBI_82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).
CC   Derived from site: Metastatic; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C25823; Mouse bladder transitional cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
RX   DOI=10.4051/ibc.2010.2.4.0014;
RA   Yoshino K., Saijo K., Noro C., Nakamura Y.;
RT   "Development of a simple method to determine the mouse strain from which
RT   cultured cell lines originated.";
RL   Interdisciplinary Bio Central 2:1-9(2010).
//
RX   PubMed=406041;
RA   Soloway M.S.;
RT   "Intravesical and systemic chemotherapy of murine bladder cancer.";
RL   Cancer Res. 37:2918-2929(1977).
//
RX   PubMed=16140114; DOI=10.1016/j.urology.2005.03.073;
RA   Horinaga M., Fukuyama R., Nishiyama T., Harsch K.M., Cicek M.,
RA   Heston W., Sizemore N., Casey G., Larchian W.A.;
RT   "Novel enhanced lung-colonizing variant of murine MBT-2 bladder cancer
RT   cells.";
RL   Urology 66:676-681(2005).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//